Product Description
Overall, the global diagnostic and interventional catheter market was valued at over $299 million in 2025. This is expected to increase over the forecast period at a CAGR of 4.4% to reach over $405 million.
The full report suite on the global market for diagnostic and interventional catheters includes a meticulous examination across seven prominent geographical regions, namely North America, Latin America, Western Europe, Central and Eastern Europe, the Middle East, Asia Pacific and Africa. Within each of these delineated regions, a comprehensive scrutiny will be conducted encompassing various facets, including market valuation, unit analysis and ASP. Moreover, the report will extend its projections up to the year 2032, thereby providing a comprehensive and anticipatory understanding of the market trends and trajectories for the given period.
Data Types Included
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Market Drivers & Limiters
- Market Forecasts Until 2032, and Historical Data to 2022
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
Global Diagnostic & Interventional Catheter Market Trends
A key emerging trend in the diagnostic and interventional catheter market is the incorporation of advanced technologies, including robotics and artificial intelligence (AI), into catheter-based procedures. Robotic-assisted systems enhance precision, control and maneuverability, while also reducing radiation exposure for both patients and clinicians. AI-enabled catheters provide real-time data analysis to support clinical decision-making during interventions. Together, these innovations are transforming the catheter landscape by facilitating more complex, minimally invasive procedures, improving patient outcomes and expanding the capabilities of interventional therapies.
Global Diagnostic & Interventional Catheter Market Share Insights
- Terumo established itself as a leading player in the hydrophilic diagnostic catheter market in 2025, while also capturing a notable share of the support catheter segment. The company pioneered hydrophilic technology with its Glidecath® catheter, which features 15 versatile tip shapes to accommodate a wide range of anatomical variations. Terumo further strengthened its position with the NaviCross® support catheter in the U.S., recognized for its excellent pushability, wire support, torque control, kink resistance, and compact crossing profile. The device’s capabilities were further enhanced with the FDA-approved 0.018” version, introduced in May 2018.
- Cook Medical’s strategic pricing strategy has been instrumental in accelerating the adoption of its devices. The company’s support catheter portfolio, including the CXI® Support Catheter, TriForce Peripheral Crossing Set, Aurous™ Centimeter and White Sizing Catheters, Beacon® Tip Catheters, Torcon NB® Advantage and CrossCath® Support Catheter, has experienced rapid uptake. The TriForce Peripheral Crossing Set, which combines a 5.0 Fr Flexor® sheath, 4.0 Fr CXI® Support Catheter and Peel-Away® sheath, has gained particular popularity and commands a premium price relative to standalone CXI® and CrossCath® support catheters. Additionally, Cook’s Beacon® Tip catheters re-entered the global market following a recall in 2015-2016.
- Cardinal Health strengthened its position in the diagnostic and interventional catheter market through the acquisition of Cordis, securing a substantial market share while maintaining its prior leadership in the support catheter segment. The company’s Vista Brite Tip® catheter is notable for its radiopaque design, engineered to provide durability and stability during lengthy or complex procedures. Cardinal Health’s strong presence in the peripheral stent market, combined with a solid foothold in PTA balloon catheters and diagnostic products, further reinforces its market dominance. By leveraging large-scale production capabilities, the company has successfully implemented an aggressive pricing strategy without eroding profit margins.
Global Diagnostic & Interventional Catheter Market Segmentation Summary
- Diagnostic and Interventional Catheter Market – Further Segmented Into:
- Device Type: Diagnostic Catheter, and Support Catheter.
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2025 |
| Forecast | 2026-2032 |
| Historical Data | 2022-2024 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
